Document 2442 DOCN M94A2442 TI High mortality but few seroconversions among hard-core drug addicts in Stockholm. DT 9412 AU Fugelstad A; Bottiger M; Romelsjo A; Agren G; Psyschiatric Dependency Clinic, S:t Goran Hospital, Stockholm. SO Int Conf AIDS. 1994 Aug 7-12;10(1):303 (abstract no. PC0142). Unique Identifier : AIDSLINE ICA10/94370133 AB OBJECTIVE: To study mortality, causes of deaths and seroconversions in relation to methadone maintenance treatment. MATERIAL AND METHOD: The study includes all intravenous heroin users who had undergone compulsory treatment in Stockholm February 1st 1986 to June 31st 1988. The cohort consists of 101 drug addicts with an intense and long standing drug abuse, who had failed in voluntary treatment. 57 addicts were HIV seropositive, 42 seronegative and in 2 cases the HIV status was not known when entering compulsory treatment. The majority of the seropositive addicts were diagnosed as such in 1984 or 1985. RESULTS: The cohort was followed up until January 1st 1994. During this period 40 addicts died. Most deaths were from violent causes, including heroin intoxication. No addict became permanently drug free. In the end of 1987 a local methadone maintenance treatment programme (MMTP) was started in Stockholm. 56 addicts in the cohort had been admitted to the programme and 32 patients were still participating in it at the end of the follow up period. The rest were discharged or had died. During the observation period 3 of the seronegative addicts seroconverted. CONCLUSION: In spite of a very intense drug abuse and high mortality rate in this cohort, there where few seroconversions. In Stockholm there has never been a needle exchange programme. A very high testing frequency among drug addicts combined with counselling may have contributed to the low rate of seroconversions. DE Cohort Studies Heroin Dependence/COMPLICATIONS/*MORTALITY/REHABILITATION Human *HIV Seropositivity Methadone/THERAPEUTIC USE Sweden/EPIDEMIOLOGY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).